Studies related to Depression and Kava

Kava-kava Extract WS 1490 Versus Placebo In Anxiety Disorders--a Randomized Placebo-controlled 25-week Outpatient Trial

Effect Decrease
Trial Design Double blind
Trial Length 6+ Months
Number of Subjects 101
Sex Both Genders
Age Range 18-29, 30-44, 45-64
Body Types Average
Notes for this study:
101 patients suffering from non-psychotic anxiety using Kava (WS 1490 extract) over 25 weeks noted statistically significant benefits starting after week 8.

Full details on all 2 studies are available to Examine Plus members.

Already a member? Login now to access.